The Biden administration entered into a contract worth about $142 million with the accounting firm in March 2021 that was meant to help accelerate access to monoclonal antibody treatments for COVID-19 patients. But several Republicans on the Senate Health Committee, including Tommy Tuberville , argue that the pricey deal did nothing to increase the supplies of the treatments, particularly during a national shortage last year.
The Department of Health and Human Services told the Washington Examiner that the contract was canceled in January 2021 due to the changing uptake and landscape of available treatments in the United States, which now include Pfizer’s antiviral Paxlovid and Merck’s molnupiravir. KPMG spokesman Russ Grote told the Washington Examiner that “KPMG is proud of our work to support all levels of government, health systems, provider networks, and more to provide greater access to life-saving treatments for underserved and disadvantaged communities during the pandemic.”
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Opinion | Biden Broke His Promise to Support Generic Covid-19 Vaccines for the World'Because the United States wields so much power at the WTO, many public health advocates assumed that if the Biden administration wanted to get a waiver passed, it could.'
Source: commondreams - 🏆 530. / 51 Read more »
FDA announces limits on who can receive Johnson & Johnson COVID-19 vaccineThe reason is a rare, but serious risk of blood clots.
Source: cbschicago - 🏆 546. / 51 Read more »
FDA restricts J&J’s COVID-19 vaccine due to blood clot riskU.S. regulators are strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots. 🤣🤣🤣🤣 Ha ha ha but they are all safe and effective right lmao. Phizer documents prove that it's only 12 percent effective. And Johnson and Johnson is just down right dangerous
Source: cleveland19news - 🏆 70. / 68 Read more »
FDA Restricts J&J's COVID-19 Vaccine Due to Blood Clot RiskU.S. regulators are strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots. The Food and Drug Administration said Thursday the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J’s vaccine. The decision is the latest restriction to hit the company’s vaccine, which has long been overshadowed in the U.S. by the more effective shots from Pfizer and Moderna. In December, the Centers for Disease Control and Prevention recommended using the Moderna and Pfizer shots over J&J’s because of its safety issues.
Source: NBCPhiladelphia - 🏆 569. / 51 Read more »
Nearly 1 million COVID-19 deaths: A look at the US numbersDoug Lambrecht was among the first of the nearly 1 million Americans to die from COVID-19. His demographic profile — an older white male with chronic health problems — mirrors the faces of many who would be lost over the next two years. Three out of every four deaths in the U.S. were people 65 and older. Charlene Harrington, an elder care expert, said she hopes lessons from the pandemic lead to changes in nursing homes. “A million things went wrong and most of them were preventable.' Fauci expected 2 million deaths in 2020, so 1 million deaths is a big W 'A look at the numbers' would seem to imply a chart or two.
Source: AP - 🏆 728. / 51 Read more »
Nearly 1 million COVID-19 deaths: A look at the US numbersThe count of U.S. deaths from COVID-19 is nearing 1 million, and there's a wealth of data making clear which groups have been hit the hardest
Source: WOKVNews - 🏆 247. / 63 Read more »